EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1802518-92-8, Minzasolmin [inn], 3n0435tg2d, Unii-3n0435tg2d, (r)-n-(1-(1h-indol-3-yl)hexan-2-yl)-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide, 5-thiazolecarboxamide, n-((1r)-1-(1h-indol-3-ylmethyl)pentyl)-2-(4-methyl-1-piperazinyl)-

Molecular Formula

C₂₃H₃₁N₅OS

Molecular Weight

425.6 g/mol

InChI Key

GDFWCSZNQVAQGR-GOSISDBHSA-N

FDA UNII

3N0435TG2D

Minzasolmin is under investigation in clinical trial NCT05543252 (An Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease).

1 2D Structure

Minzasolmin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(2R)-1-(1H-indol-3-yl)hexan-2-yl]-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide

2.1.2 InChI

InChI=1S/C23H31N5OS/c1-3-4-7-18(14-17-15-24-20-9-6-5-8-19(17)20)26-22(29)21-16-25-23(30-21)28-12-10-27(2)11-13-28/h5-6,8-9,15-16,18,24H,3-4,7,10-14H2,1-2H3,(H,26,29)/t18-/m1/s1

2.1.3 InChI Key

GDFWCSZNQVAQGR-GOSISDBHSA-N

2.2 Other Identifiers

2.2.1 UNII

3N0435TG2D

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 1802518-92-8

2. Minzasolmin [inn]

3. 3n0435tg2d

4. Unii-3n0435tg2d

5. (r)-n-(1-(1h-indol-3-yl)hexan-2-yl)-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide

6. 5-thiazolecarboxamide, N-((1r)-1-(1h-indol-3-ylmethyl)pentyl)-2-(4-methyl-1-piperazinyl)-

7. 5-thiazolecarboxamide, N-[(1r)-1-(1h-indol-3-ylmethyl)pentyl]-2-(4-methyl-1-piperazinyl)-

8. N-((1r)-1-(1h-indol-3-ylmethyl)pentyl)-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide

9. N-[(2r)-1-(1h-indol-3-yl)hexan-2-yl]-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide

10. Minzasolmina

11. Minzasolmine

12. (r)-n-[1-(1h-indol-3-yl)hexan-2-yl]-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide

13. N-[(1r)-1-(1h-indol-3-ylmethyl)pentyl]-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide

14. Minzasolmin (usan/inn)

15. Minzasolmin [usan]

16. Dlx313

17. Chembl5095072

18. Schembl16973853

19. Dlx-313

20. Bdbm510823

21. Glxc-26948

22. Ex-a6318

23. Ucb-0599

24. Da-65474

25. Hy-145580

26. Us11078196, Ex. 28

27. Cs-0376408

28. D12796

29. (r)-n-(1-(1h-indol-3-yl)hexan- 2-yl)-2-(4-methylpiperazin-1- Yl)thiazole-5-carboxamide

30. N-[(1r)-1-(1h-indol-3-ylmethyl)pentyl]-2-(4-methyl-1-piperazinyl)-5-thiazolecarboxamide

2.4 Create Date

2016-02-23

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₃₁N₅OS
Molecular Weight	425.6 g/mol
XLogP3	4.8
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	8
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	92.5
Heavy Atom Count	30
Formal Charge	0
Complexity	556
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1